ARTICLE | Clinical News
RHB-104 regulatory update
January 25, 2017 2:43 AM UTC
FDA granted Qualified Infectious Disease Product (QIDP) and Fast Track designation to RHB-104 from RedHill to treat non-tuberculosis mycobacterial (NTM) infections. The product is a capsule formulatio...
BCIQ Company Profiles